# Alfentanil

## Rapifen inj 1mg/2mL

| 藥物代碼           | IRAP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | an analgesic supplement and an anaesthetic induction agent.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 副作用             | CommonCardiovascular: Hypertension (18% ), Tachycardia (12% )Gastrointestinal: Nausea (28% ), Vomiting (18% )Musculoskeletal: Involuntary movement, Skeletal muscle (3% to 9% )SeriousCardiovascular: Asystole, Bradyarrhythmia, Cardiac dysrhythmia, Hypotension (10% )Immunologic: Anaphylaxis (Less than 1% )Musculoskeletal: Muscle rigidity (17% )Neurologic: Raised intracranial pressure, SeizureRespiratory: Apnea (3% to 9% ), Laryngeal spasm (0.3% to 1% ), Respiratory depression (1% to 3% )Other: Serotonin syndrome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 禁忌               | Hypersensitivity to alfentanil or any component of the formulation. known intolerance to alfentanil.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 藥物保存方式       | 15-30℃                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 用法用量           | Use as an Induction Agent: An intravenous bolus dose of > or =120 micrograms/kg (17mL/70kg) RAPIFEN will induce hypnosis and analgesia while maintaining good cardiovascular stability in patients with adequate muscle relaxation. For short procedures, an initial dose 7-15 micrograms/kg at induction, with intermittent boluses up to 15 micrograms/kg (7-15 micrograms/kg) at 10-15 minute intervals are most useful. If the dose is less than 7micrograms/kg and IV injection slowly, most patients can still maintain normal respiratory function. the recommended additional dose is 3.5micrograms/kg. For procedures of longer duration, a higher dose may be given at induction and further increments titrated to effect. Duration of the procedure(min):10-30; Rapifen IV bolus dose: 20-40 Micrograms/kg ; 3-6mL/70kg; Duration of the procedure(min):30-60; Rapifen IV bolus dose: 40-80 Micrograms/kg ; 6-12mL/70kg; Duration of the procedure(min):>60; Rapifen IV bolus dose: 80-150 Micrograms/kg ; 12-20mL/70kg; When surgery is more prolonged or more traumatic, analgesia should be maintained by: ‧ either increments of up to 15 micrograms/kg (2mL/70kg) RAPIFEN when required (to avoid post-operative respiratory depression, no RAPIFEN should be administered during the last 10 minutes of surgery); ‧ or a RAPIFEN infusion at a rate of 0.5 to 1 microgram/kg/min (0.14mL/70kg/min) until 5 to 10 minutes before the completion of surgery. Continuous infusion is preferable for cases greater than 60 minutes duration. Rapifen should not be given in the last 10 minutes prior to completion of surgery. |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 孕期用藥建議       | Human data suggest risk in 3rd trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 附帶說明           | [仿單]雖然在動物實驗並沒有發現畸形或急性胎毒效應，但目前仍然沒有足夠的數據可用以評估對人類的任何有害作用。因此孕婦於給藥前應做審慎的利弊評估。 在分娩(包括剖腹生產)的過程不建議靜脈注射本品，因為Rapifen會穿過胎盤，可能會抑制新生兒的自然呼吸。 如於分娩時使用Rapifen，應備妥輔助呼吸設備供母嬰需要時使用，鴉片類藥物的拮抗劑應事先為胎兒備妥。 鴉片類藥物拮抗劑的半衰期可能比Alfentanil的半衰期短，因此多劑量投與鴉片類藥物拮抗劑可能是必要的。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 附帶說明           | [仿單]Rapifen會分泌到乳汁中。因此，在Rapifen給藥後的24小時內不要授乳或餵哺擠出的母乳。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 注射劑給藥建議途徑 | IVD, IVPUSH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 輸注點滴液         | 【D5W】 可選 仿單建議  【N/S】 可選 仿單建議                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| IVP 用法建議       | Administer doses slowly over at least 3 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| IVD 用法建議       | Alfentanil was diluted to a concentration of 25 to 80 mcg/mL in clinical studies. _____________________________________________________________________________ 手術時間(分鐘) Rapifen靜脈注射一次給藥劑量(mcg/Kg) mL/70Kg 10-30 20~40 3-6 30-60 40~80 6-12 > 60 80~150 12-20                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 注意事項           | Duration, general anesthesia: Discontinue use at least 10 to 15 minutes prior to the end of surgery Rapifen不可和其他藥品混合.可以混合氯化鈉或葡萄糖靜脈輸注溶液,需在24小時內使用完畢.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

## Rapifen inj 1mg/2mL 殘餘銷毀

| 藥物代碼           | IRAPBAD                  |
|:-------------------|:-------------------------|
| 適應症             | NA                       |
| 副作用             | NA                       |
| 禁忌               | NA                       |
| 藥物保存方式       | N/A                      |
| 用法用量           | N/A                      |
| 肝功能異常         | 無需調整劑量  需調整劑量 |
| 腎功能異常         | 無需調整劑量  需調整劑量 |
| 懷孕用藥危分級     | 尚未確立                 |
| 孕期用藥建議       | N/A                      |
| 附帶說明           | N/A                      |
| 哺乳期用藥建議     | N/A                      |
| 附帶說明           | N/A                      |
| 注射劑給藥建議途徑 | IV, IVPUSH               |
| 乾粉稀釋液         | N/A                      |
| 輸注點滴液         | N/A                      |
| IVP 用法建議       | N/A                      |
| IVD 用法建議       | N/A                      |
| 注意事項           | N/A                      |

